جست‌وجوی استاد و پژوهشگر

Gaurav Marwahaمشاهده پروفایل

دانشیار

• Radiation Oncology
• Lung Cancer
• Stereotactic Radiosurgery
• +۳ مورد دیگر

Gaurav Marwaha, MD is an Associate Professor in the Department of Radiation Oncology at Rush Medical College, Rush University. He maintains clinical practice across multiple locations including RUSH MD Anderson Cancer Center in Chicago, Rush Radiation Oncology - Oak Park, Rush Lung Center - Oak Park, and RUSH MD Anderson Cancer Center at Rush Lisle. His work focuses on providing cutting-edge radiation therapy while emphasizing compassionate patient care, stating that being part of curing early-stage cancers or alleviating discomfort is the most rewarding aspect of being a physician. Dr. Marwaha's research interests span radiation oncology with particular expertise in lung cancer treatment, stereotactic radiosurgery, brachytherapy, and ocular oncology. His clinical expertise includes brain tumors, chest tumors, esophageal cancer, Hodgkin lymphoma, intensity-modulated radiation therapy, mediastinal tumors, mesothelioma, non-Hodgkin lymphoma, palliative radiation therapy, spinal cancers, and thymoma. His approach emphasizes multidisciplinary care, telling patients 'we got you and we got this, and you have a team here' to navigate their cancer journey. His publication record shows a consistent focus on advancing radiation oncology techniques and addressing systemic issues in cancer care. The most recent works examine difficult decisions in non-small cell lung cancer treatment, chemoradiation protocols for elderly patients, automated treatment planning, and workforce dynamics in radiation oncology. His research bridges technical advancements in radiation delivery with broader considerations of patient care and professional development in the field. Dr. Marwaha is board certified in Radiation Oncology with educational background from University of Cincinnati College of Medicine (medical school) and Cleveland Clinic Foundation (residency). He emphasizes that radiation oncology sits at 'the crossroads of so many fields within cancer care,' highlighting how advancements have enabled higher quality treatment with less impact on patients' lives while maintaining excellent outcomes.

Isabella Fornacon-Woodمشاهده پروفایل

پژوهشگر

• Radiation Therapy
• Lung Cancer
• Radiomics
• +۳ مورد دیگر

Isabella Fornacon-Wood is a Researcher at The University of Manchester's Division of Cancer Sciences, based at The Christie Hospital. She focuses on applying statistical methods to real-world patient data to improve cancer outcomes, particularly for under-represented groups. Her expertise includes radiomics, radiation therapy optimization, and pandemic impact analysis. Education: PhD in Cancer Sciences, The University of Manchester (2018–2023) MRes in Translational Medicine, The University of Manchester (2017–2018) BSc in Physics, Universitat Leipzig (2014–2017) Research Interests: Lung cancer treatment optimization via radiomics and real-world data Statistical analysis of radiation therapy outcomes Impact of pandemics on oncology care delivery Her recent work includes developing CT-based radiomic guidelines, analyzing patient-reported outcomes in oncology, and evaluating UK radiotherapy adaptations during the pandemic. Grants & Collaboration: Collaborations with institutions across the UK and international oncology networks Supervised by Prof. Faivre-Finn and Dr. Price in her PhD on real-world data applications Lab Affiliations: Radiotherapy Related Research Group at The Christie Hospital.

Jeffrey L. Wintersمشاهده پروفایل

استاد

• Transfusion Medicine
• Therapeutic Apheresis
• Blood Banking
• +۵ مورد دیگر

Jeffrey L. Winters is a Professor of Laboratory Medicine and Pathology at the Mayo College of Medicine . He serves as Chair of the Division of Transfusion Medicine and Associate Program Director of the Mayo Clinic Transfusion Medicine/Blood Banking Fellowship Program. As Medical Director of the Therapeutic Apheresis Treatment Unit (performing 3,000 annual procedures), his clinical leadership spans transfusion medicine, apheresis therapies, and blood banking operations. Education: MD (University of Kentucky College of Medicine, 1993, with High Distinction); Anatomic/Clinical Pathology Residency (University of Kentucky); Transfusion Medicine/Blood Banking Fellowship (Mayo Clinic, 1999) Certifications: American Board of Pathology (Anatomic Pathology, Clinical Pathology, Blood Banking/Transfusion Medicine) His research focuses on therapeutic apheresis applications , including: Immune modulation in cancer immunotherapy Coagulation profiles in infectious disease (e.g., COVID-19 convalescent plasma) Drug-induced thrombotic microangiopathies Autoimmune hemolytic anemia treatment protocols Recent publications highlight his work in plasma exchange for ICU patients and directed blood donation ethics. He leads the Mayo Clinic Enterprise Apheresis Working Group and chairs AABB Biotherapies Advisory Group. Scientific honors include: Mayo Clinic Excellence Through Teamwork Award (2022) Memorial Blood Centers Dr. Herbert F. Polesky Award (2021) Francis Morrison Award & Lecture (2019) Multiple Clinical Pathology Teacher of the Year awards (2005, 2009, 2011) He serves on the Board of Directors for AABB and as Editor-in-Chief for the Journal of Clinical Apheresis . His professional memberships encompass American Society for Apheresis (past president), College of American Pathologists, and American Association of Blood Banks.

Jennifer De Los Santosمشاهده پروفایل

استاد

• Breast Cancer
• Radiation Therapy
• Head and Neck Cancers
• +۵ مورد دیگر

Jennifer De Los Santos, MD is a Professor of Radiation Oncology at Washington University School of Medicine in St. Louis. She serves in the Department of Radiation Oncology and is part of the Siteman Cancer Center. Dr. De Los Santos is a nationally recognized expert in breast cancer although her current clinical and research focus centers on cancers of the head and neck. She has held leadership positions including Chairman of Radiation Oncology and Cancer Center Director at Grandview Cancer Center in Birmingham, Alabama, and has led national studies in breast cancer through the TBCRC and NRG oncology groups. Dr. De Los Santos' educational background includes a BS in Psychology from Emory University (1991), an MD from the University of Florida (1995), and completed her residency in Radiation Oncology at MD Anderson Cancer Center (2001). Her research interests span breast cancer treatment, radiation therapy techniques, and head and neck cancers, with particular focus on developing paradigm-shifting treatment approaches and translational work to define populations who may successfully proceed with these approaches. Her publication record demonstrates consistent productivity with 68 research outputs and 2973 citations. Recent work shows a strong focus on breast cancer staging systems, pathological response prediction, and innovative treatment approaches including novel combinations of targeted therapies with radiation. Her research often involves large national clinical trials through NRG Oncology and other cooperative groups. Dr. De Los Santos has served in leadership roles at the Translational Breast Cancer Research Consortium (TBCRC), the University of Alabama at Birmingham, and has been involved in numerous national clinical trials that have shaped breast cancer treatment guidelines. Her work bridges clinical practice and research, with emphasis on improving outcomes for cancer patients through innovative treatment approaches and better understanding of treatment response predictors.

S. Murty Godduمشاهده پروفایل

استاد

• Radiation Oncology
• Medical Physics
• Quality Assurance (QA)
• +۶ مورد دیگر

S. Murty Goddu, PhD is a Professor of Radiation Oncology at Washington University School of Medicine. He earned his BS, MS, and PhD in Physics and Nuclear Physics from Andhra University, India, and completed a residency in medical physics at Washington University. His work focuses on quality assurance (QA) for radiation therapy systems, including linear accelerators, helical tomotherapy, and proton therapy. He has contributed to developing QA tools for 3D-conformal therapy, IMRT, Gamma-Knife, brachytherapy, and radiopharmaceutical treatments. Education: BS, Physics: Andhra University (1983) MS, Nuclear Physics: Andhra University (1985) PhD, Nuclear Physics: Andhra University (1991) Residency, Medical Physics: Washington University School of Medicine (1999) Certifications: American Board of Radiology, Therapeutic Medical Physics (2001) His research emphasizes improving patient safety through QA innovations, such as automated commissioning of radiotherapy systems, electronic chart checks, and deformable image registration. He has published extensively on topics like CBCT volumetric coverage extension , metal artifact reduction , and monitor unit calculations . Selected publications highlight advancements in: Proton therapy commissioning Helical tomotherapy QA Y-90 microsphere delivery protocols Bone marrow radiotoxicity studies Deformable image registration software (DIRART) Multimodality image registration He has collaborated with institutions on clinical trials and protocols for adaptive radiotherapy, dose calculation validation, and patient-specific QA. His work bridges physics, engineering, and clinical oncology to enhance treatment accuracy and safety.

Pamela Samsonمشاهده پروفایل

استادیار

• Lung Cancer
• Esophageal Cancer
• Radiation Oncology
• +۳ مورد دیگر

Pamela Samson is an Assistant Professor of Radiation Oncology at Washington University School of Medicine (WashU Medicine), with clinical interests in lung cancer , cardiac arrhythmias , GI malignancies , and esophageal cancer . She completed her MD and MPHS at WashU Medicine and holds advanced degrees in chemistry , anthropology , international studies , and molecular physiology . Her research focuses on lung and esophageal cancer outcomes , radiation therapy toxicities , and decision analysis for treatment allocation. She has authored over 94 publications, including peer-reviewed articles on stereotactic body radiation therapy (SBRT) , cardiotoxicity in thoracic radiotherapy, and 3D dose prediction using AI models. Notable awards include the Peter T. Klogour Salutatorian Prize , induction into Alpha Omega Alpha , and membership in the Arnold P. Gold Humanism Honor Society . She serves on the American Cancer Society National Lung Cancer Roundtable Committee and the Journal of Thoracic Disease editorial board. Her clinical work emphasizes multi-modality therapy for thoracic malignancies and cost-effectiveness analyses of radiation treatment strategies. She has conducted research fellowships in cardiothoracic surgery and maintains affiliations with the Institute of Clinical and Translational Sciences (ICTS) and Siteman Cancer Center .

• Radiation Oncology
• Translational Research
• Clinical Trials
• +۳ مورد دیگر

Kristine E. Kokeny, MD is an Associate Professor in the Department of Radiation Oncology at the University of Utah and a physician at Huntsman Cancer Institute , where she contributes to multidisciplinary teams for breast , lung , and genitourinary cancer care. Clinical Expertise: Radiation therapy for breast, lung, and genitourinary malignancies. Research Focus: Translational research and clinical trials evaluating novel therapies to enhance treatment outcomes and survival. Her recent publications emphasize radiation therapy techniques (e.g., IMRT, SBRT), cancer-specific outcomes , and health disparities . Dr. Kokeny is certified by the American Board of Radiology and is a member of prominent oncology societies, including ASTRO and ASCO .

Marilyn N. Lingمشاهده پروفایل

دانشیار

• Radiation Oncology
• Breast Cancer
• Radiation Treatment Modalities
• +۳ مورد دیگر

Marilyn N. Ling, M.D., is an Associate Professor of Radiation Oncology at the University of Rochester Medical Center's School of Medicine and Dentistry. She is actively involved in clinical practice and research, focusing on breast cancer treatment and radiation therapy innovations. Board-certified by the American College of Radiology Co-Medical Director of the Integrative Oncology and Wellness Center Member of the American Society for Therapeutic Radiology and Oncology Education: B.A. in Biology, Williams College (1983) Certificat de Merité, Cordon Bleu Académie Cuisine (1984) M.D., University of Maryland School of Medicine (1988) Residency in Radiation Oncology, Johns Hopkins Hospital (1989-1992) Research Interests: Dr. Ling specializes in advanced radiation treatment modalities, including stereotactic body radiotherapy and intensity modulated radiotherapy. Her work addresses breast cancer management, focusing on breast conserving therapy, reconstruction techniques, and mitigation of radiation therapy side effects such as bone loss, nausea, radiation dermatitis, and fatigue. She has contributed extensively to integrative approaches in oncology. Scientific Awards: Angel Award (2016) Jacob Gitelman Award (2016) Heart & Hands Award (2013) Rubin-Mitchell Teaching Award (2004) Publications Trends: Dr. Ling's research spans clinical trials (curcumin for radiation dermatitis), technical advancements (IMRT dosimetry), and integrative medicine applications in oncology. Her work emphasizes patient-centered outcomes, particularly in breast cancer survivorship and symptom management.

• Radiation Oncology
• Urologic Malignancies
• Prostate Cancer Treatment
• +۳ مورد دیگر

Joseph G. Cardinale, MD, is an Associate Clinical Professor of Therapeutic Radiology at Yale School of Medicine. He specializes in radiation oncology with over 30 years of expertise in treating urologic malignancies, particularly prostate cancer. His clinical practice emphasizes individualized patient care using advanced techniques like radiosurgery, brachytherapy, and IMRT. He leads a prostate cancer program at Yale Medicine and engages in outreach for medically underserved communities. His research focuses on minimizing organ removal in cancer treatment. Education: BS, Manhattan College (1976) MD, New York Medical College (1980) Residency in Therapeutic Radiology, Yale-New Haven Hospital (1984) Board Certifications: Therapeutic Radiology (AB of Radiology, 1984) Key Contributions: Developed a prostate cancer program at Yale Medicine; advocates for minimally invasive cancer therapies to preserve organ function. Conducts clinical research to improve treatment efficacy with reduced side effects. Contact: Based at Yale New Haven Hospital, reachable via joseph.cardinale@yale.edu or (203) 789-3131.

• Acute Lymphoblastic Leukemia
• Pediatric Brain Tumors
• Genetic Heterogeneity
• +۵ مورد دیگر

Stephen E. Sallan, MD , is a Professor of Pediatrics at Harvard Medical School and a Physician at Dana-Farber Cancer Institute and Children's Hospital . His career spans over five decades in pediatric hematology/oncology , with a focus on acute lymphoblastic leukemia (ALL) and pediatric brain tumors . Education : MD, Wayne State University School of Medicine (1967) Residencies : Boston Floating Hospital (1968), Children's Hospital of Philadelphia (1969), Hospital for Sick Children, London (1970) Fellowship : Pediatric Oncology, Children's Hospital/DFCI (1972) Leadership Roles : Chief of Staff (1995), Chairman of Medical Staff Executive Committee (1995), Chief of Staff Emeritus (2012) Dr. Sallan's research integrates genetic heterogeneity , disease recurrence , and drug resistance in ALL, with efforts to develop targeted therapies like tumor vaccines and antiangiogenesis agents. His work addresses long-term treatment toxicities (cardiac, skeletal, neurocognitive), particularly in survivors of childhood cancers. His 15 most recent publications (2024–2018) demonstrate ongoing engagement with pharmacogenomics, thrombosis risk models, dietary interventions, and molecular markers in brain tumors. Key subfields include TRK-C in medulloblastoma , asparaginase complications , and DFCI ALL Consortium Protocols . Scientific Awards : Distinguished Alumni Award, Wayne State University School of Medicine (1997) James Carreras Prize for International Pediatrician of the Year (1987) As a leader in pediatric leukemia research , Dr. Sallan has shaped treatment protocols that minimize late effects while improving survival. He collaborates with multidisciplinary teams in neuro-oncology and pharmacogenomics, maintaining active roles in clinical trials and laboratory investigations.

Shirin Abbasinejad Engerمشاهده پروفایل

دانشیار

• Medical Physics
• Radiation Oncology
• Brachytherapy Technology
• +۵ مورد دیگر

Dr. Shirin Abbasinejad Enger is an Associate Professor at the Gerald Bronfman Department of Oncology, McGill University, and Director of the Medical Physics Unit. She holds a Tier 2 Canada Research Chair in Medical Physics and serves as research director at the Lady Davis Institute and Segal Cancer Centre (Jewish General Hospital). Her leadership roles include chairing the AAPM's TG-337 (Intensity Modulated Brachytherapy) and contributing to national/international committees on equity and radiation oncology standards. Education: PhD from Uppsala University (2009), postdoctoral research at Université Laval (2009–2011). Research focuses on advancing medical physics technologies, with four key axes: Novel brachytherapy techniques (e.g., Yb-169 for prostate cancer) Radiobiology/microdosimetry (e.g., alpha particle dosimetry) Detector development (e.g., scintillating fiber detectors, hydrated electron dosimeters) Artificial intelligence integration (e.g., deep learning for dose prediction) Publications emphasize precision dosimetry, brachytherapy optimization, and medical imaging innovations. Awards include multiple medical innovation prizes and the Young Investigator award at Curietherapies 2022. Grants and collaborations: Competitive funding for technology translation from concept to clinical trials, with patents on brachytherapy delivery systems and radiation dosimeters. Leads the EngerLab, fostering interdisciplinary research in radiation oncology.

• Prostate Cancer
• Clinical Trials
• Oncology
• +۴ مورد دیگر

Dr. Martin Russell is an Honorary Clinical Senior Lecturer at the School of Cancer Sciences, University of Glasgow, specializing in prostate cancer research and clinical trials. His work spans hormone therapy, chemotherapy, and radiotherapy for prostate and urinary tract cancers. Recent research focuses on the STAMPEDE platform protocol for prostate cancer treatment optimization, including combinations of abiraterone, enzalutamide, docetaxel, and radiotherapy. Key contributions include cost-effectiveness analyses and survival outcome studies. He has collaborated extensively on large-scale clinical trials and published in journals like Lancet Oncology , New England Journal of Medicine , and BJU International . His email address is Martin.Russell@glasgow.ac.uk .

Wendla K. Citronمشاهده پروفایل

استادیار بالینی

• CNS malignancies
• Head and neck cancer
• Lung cancer
• +۱۱ مورد دیگر

Wendla K. Citron is a Clinical Assistant Professor in the Department of Radiation Oncology at the University of Maryland School of Medicine. She serves as Medical Director of the Tate Cancer Center at University of Maryland Baltimore Washington Medical Center and co-directs the Radiation Oncology Residency Program. Education: Bachelor of Science in Biology from MIT (1996), MD from Wake Forest University School of Medicine (2001). Training: Internship in Internal Medicine (2002), Residency in Radiation Oncology at the University of Chicago (2006). Dr. Citron specializes in treating diverse malignancies (CNS, breast, head/neck, lung, GI, GU, gynecologic, lymphoma, and sarcoma) with advanced radiation modalities including 3D Conformal Radiation Therapy , Proton Therapy , and Image Guided Radiation Therapy . Her research emphasizes breast cancer , radiation oncology innovations , and improving treatment outcomes for elderly patients. Her publications focus on breast cancer treatment protocols, radiation therapy efficacy, and health disparities in oncology. Dr. Citron's clinical expertise extends to breast conservation therapy, leveraging technical advances to minimize side effects and treatment inconvenience.

Mark Oldhamمشاهده پروفایل

استاد

• FLASH radiation therapy
• Radiation and Immunotherapy
• Radiation Therapy Enhanced by Cherenkov photo-Activation (RECA)
• +۶ مورد دیگر

Mark Oldham is Professor of Radiation Oncology and Professor of Physics at Duke University, where he also serves as Director of the Duke Medical Physics MS/PhD Graduate Program and is a Member of the Duke Cancer Institute. His academic career spans over three decades with progressive appointments from Instructor to full Professor in Radiation Oncology. Dr. Oldham received his Ph.D. from Newcastle University (United Kingdom) in 1991. His research interests focus on innovative approaches to radiation therapy, particularly FLASH radiation therapy using the Duke High Intensity Gamma Source (HIGS), radiation and immunotherapy utilizing mini-grids, Radiation Therapy Enhanced by Cherenkov photo-Activation (RECA), and comprehensive 3D dosimetry systems. His work has been recognized with multiple Paper of the Year awards from SEAAPM and the prestigious Farrington Daniel Award from AAPM. His recent publications demonstrate a strong focus on 3D dosimetry systems, radiation therapy verification techniques, and novel cancer treatment approaches. His research integrates advanced dosimetry methods with innovative radiation therapy techniques to improve cancer treatment outcomes. His work on polymer gel dosimetry, optical CT scanning, and radiation-immunotherapy combinations represents cutting-edge developments in the field. Dr. Oldham's scientific achievements have been recognized through multiple awards including the Paper of the Year (2018, 2017), Farrington Daniel Award (2016, 2002), Excellence in Teaching (2014), Excellence in Mentoring (2011), and Fellow of the AAPM (2010). He has also received the Director's Award for Exemplary Service multiple times. As a principal investigator and co-investigator, Dr. Oldham has secured significant research funding from the National Institutes of Health, National Institute of Dental and Craniofacial Research, and Ian's Friends Foundation. His current research portfolio includes exploring synthetic lethality with high energy electron FLASH radiation beams, super-FLASH therapy for pediatric brain tumors, and radiation protection mechanisms. He serves on the Board of Directors of the American Association of Medical Physics and has made significant contributions to medical physics education through his leadership of Duke's Medical Physics Graduate Program.

Laura Fitzgerald Hall Allenمشاهده پروفایل

استادیار

• Radiation Oncology
• Cancer Treatment Technologies
• Breast Cancer Research
• +۴ مورد دیگر

Laura Fitzgerald Hall Allen, MD serves as an Assistant Professor in the Department of Radiation Oncology at Wake Forest University School of Medicine, Winston-Salem campus. She is board certified in radiation oncology and provides clinical cancer treatment services at the Atrium Health Wake Forest Baptist Hayworth Cancer Center in High Point, NC. Wake Forest University School of Medicine - Faculty Member Atrium Health Wake Forest Baptist - Clinical Provider Hayworth Cancer Center - Primary Practice Location Dr. Allen received her undergraduate education from Tulane University and earned her medical degree from the Medical College of Georgia School of Medicine in 1995. She completed her Internal Medicine residency at Emory Healthcare in 1996, followed by specialized training in Radiation Oncology at Memorial Sloan Kettering Cancer Center in 2000. Additional training was completed at Wake Forest University Baptist Medical Center in 2018. Dr. Allen specializes in comprehensive radiation oncology with expertise across multiple cancer types including breast, prostate, lung, and gastrointestinal cancers. Her technical proficiency spans External Beam Radiation, Image-Guided Radiotherapy, Intensity Modulated Radiotherapy (IMRT), and Volumetric Arc Radiotherapy (VMAT). She is deeply committed to patient-centered care, treating each patient as if they were family members, with the mission of bringing Wake Forest University School of Medicine's expertise into community practice settings. Her clinical approach emphasizes personalized treatment plans for patients navigating challenging cancer journeys. American Board of Radiology certification in Radiation Oncology Member of the American Society for Therapeutic Radiation and Oncology Dr. Allen maintains an exceptional patient satisfaction record with a 4.9/5.0 rating based on 81 verified patient reviews. Patients consistently praise her compassionate communication style, thorough explanations of medical conditions, attentive listening skills, and dedication to addressing concerns. Her practice accepts numerous insurance providers across the Wake Forest Baptist Health system, serving patients at the High Point location with office hours Monday through Friday from 8:00 AM to 5:00 PM.